Soligenix
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
29 Emmons Dr Ste B10, Princeton, New Jer...Phone Number
(609) 538-8200Website
www.soligenix.comRevenue
<$5 MillionStock Symbol
SNGXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Soligenix
Soligenix is a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics.Explore more
Soligenix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Soligenix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Soligenix, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Soligenix
Product Launch: Get notified when Soligenix launches new products
Check out if Soligenix is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Soligenix recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Soligenix had a recent Job posting/layoffs
Check if Soligenix has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Soligenix has new funding data
Recommended Actions
Find VP level buyers at Soligenix
Find more new buyers
Compare Similar Companies to Soligenix
Compare insights from companies similar to Soligenix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Soligenix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Soligenix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Soligenix.
Soligenix financials insights
Gather financial insights about Soligenix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$7.1M
2020
Debt
$350K
Debt
$20M
2025
Stock/Share Issuance
$7.5M
Soligenix Tech Stack
A closer look at the technologies used by Soligenix
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Pharmaceuticals
Person-Based
Medical Research, Clinical Operations
Soligenix News & Media
Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
Thermostability, immunogenicity and efficacy data against related viruses may provide rapid starting point for vaccine development PRINCETON, N.J., May 26, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on...Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates...Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
PRINCETON, N.J., April 28, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Data...Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
HyBryte™ demonstrates more rapid and robust treatment response compared to Valchlor® during 12-week treatment course PRINCETON, N.J., April 2, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Soligenix
Sign Up For FreeTo access detailed company insights
Soligenix is a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics.... Read More
